Omics! Omics!

When the human genome was still terra incognito (or, at least our knowledge of the sequence was something like my view of the world sans my ...

Gene Logic today announced that Pfizer has filed a patent based on a Gene Logic drug repositioning effort. This would appear to be one of t...

I'm no fan of the local TV news broadcasts & therefore rarely catch them. So it was quite by accident that I caught a story last ni...

A significant challenge in pharmacology is the correct dosing of the drug. "The dose makes the poison" is an adage in toxicology,...

One of the journals I monitor by RSS is Nucleic Acids Research, and the usual steady flow of new items has become a torrent, mostly about d...

Marilyn vos Savant is a writer of a regular column in Parade magazine. These columns address many things, but often have interesting logic...

One component of many employment benefit packages in the U.S. (I don't know about other countries) is a Medical Flexible Spending Accoun...

A large lung cancer genomics study has been making a big splash. Using SNP microarrays to look for changes in the copy number of genes acr...

Tonight, of course, is Halloween, one of the many holidays which in the U.S. has a serious sweet tooth. After taking Version 2.0 around for...

Officially, I started this blog a year ago yesterday , with the first post about science coming the next day . At times, I wonder what posse...

One of the many attractions of the next generation sequencing techniques is that they eliminate the step of cloning in E.coli the DNA to be ...

G-protein coupled receptors, or GPCRs, are a key class of eukaryotic membrane receptors. Roughly 50% of all small molecule therapeutics tar...

Sometimes in life, you just want to lie back and stare at the ceiling. Other times, you have no choice, which is how I found myself for a w...

As the Harry Potter series went on, more and more of the characters' names telegraphed a key component of their properties. One of the ...

Last week's Science contained the p ublication of the Chlamydomonas reinhardtii genome , an old friend of mine from my undergraduate day...

Anyone interested in personal genomics should hunt down the new Nature (available online at the moment) and read the story of Hugh Rienhoff ...

I admire Richard Branson for his many entrepreneurial and adventuring efforts. I am especially wishing for the success of his spaceflight v...

For a number of years now I think of early October as Nobel season. With the prizes often come two rounds of silliness. The fun silliness a...

Visitors to our house are likely to quickly notice a recurrent theme in the decor, starting with a garden ornament and continuing throughout...

I had commented a while back that I was contemplating shifting my programming focus from Perl to another language. The existing code base ...